G. David Roodman

School of Medicine, Medicine, Hematology/Oncology

• Home
• Expert Overview
• Profile
• Publications
• Grants
• Patents
• Similar Experts
• Journals
• Trends
• Institutional Network
• Coauthor Network
• Research Network
• Curriculum Vitae

G. David Roodman

• School of Medicine
  School of Medicine
  
  Medicine
  
  Hematology/Oncology
  
  

  Current Appointments:

  Professor of Medicine

  
  
  

This is a list of publications by this researcher, listed chronologically starting with the most recent first. New publications appear in this list weekly. The source of publications and 'cited by' data for this application is Scopus.

  Select All    |   Export

• 1.

  2013

  Feng-Ming Wang; Aliye Sarmasik; Yuko Hiruma; Quanhong Sun; Bénédicte Sammut; Jolene J. Windle; G. David Roodman; Deborah L. Galson

  Measles virus nucleocapsid protein, a key contributor to Paget's disease, increases IL-6 expression via down-regulation of FoxO3/Sirt1 signaling

  Bone. 2013;53(1):269-276.
  0

• 2.

  2012

  G. David Roodman

  Genes associate with abnormal bone cell activity in bone metastasis

  Cancer and Metastasis Reviews. 2012;31(3-4):569-578.
  0

• 3.

  2012

  Peng Yang; Kyaw-Zeyar Myint; Qin Tong; Rentian Feng; Haiping Cao; Abdulrahman A. Almehizia; Mohammed Hamed Alqarni; Lirong Wang; Patrick Bartlow; Yingdai Gao; et al.

  Lead discovery, chemistry optimization, and biological evaluation studies of novel biamide derivatives as CB₂ receptor inverse agonists and osteoclast inhibitors

  Journal of Medicinal Chemistry. 2012;55(22):9973-9987.
  2

• 4.

  2012

  J.R. Kovacs; C. Li; Q. Yang; G. Li; I.G. Garcia; S. Ju; D.G. Roodman; J.J. Windle; X. Zhang; B. Lu

  Autophagy promotes T-cell survival through degradation of proteins of the cell death machinery

  Cell Death and Differentiation. 2012;19(1):144-152.
  12

• 5.

  2012

  Sonia D'Souza; Noriyoshi Kurihara; Yusuke Shiozawa; Jeena Joseph; Russell Taichman; Deborah L. Galson; G. David Roodman

  Annexin II interactions with the annexin II receptor enhance multiple myeloma cell adhesion and growth in the bone marrow microenvironment

  Blood. 2012;119(8):1888-1896.
  6

• 6.

  2012

  G. David Roodman

  Vitamin E: Good for the heart, bad for the bones?

  Nature Medicine. 2012;18(4):491-492.
  0

• 7.

  2012

  Guoshuang Xu; Kai Liu; Judy Anderson; Kenneth Patrene; Suzanne Lentzsch; G. David Roodman; Hongjiao Ouyang

  Expression of XBP1s in bone marrow stromal cells is critical for myeloma cell growth and osteoclast formation

  Blood. 2012;119(18):4205-4214.
  0

• 8.

  2012

  Suzanne Lentzsch; Amy O'Sullivan; Ryan C. Kennedy; Mohammad Abbas; Lijun Dai; Silvana Lalo Pregja; Steve Burt; Michael Boyiadzis; G. David Roodman; Markus Y. Mapara; et al.

  Combination of bendamustine, lenalidomide, anddexamethasone (BLD) in patients with relapsed or refractory multiple myeloma is feasible and highly effective: Results of phase 1/2 open-label, doseescalation study

  Blood. 2012;119(20):4608-4613.
  10

• 9.

  2011

  Michal T. Krauze; G. David Roodman

  Bortezomib and osteoclasts and osteoblasts

  Milestones in Drug Therapy. 2011;37:43-52.
  0

• 10.

  2011

  G. David Roodman

  Osteoblast function in myeloma

  Bone. 2011;48(1):135-140.
  12

• 11.

  2011

  Noriyoshi Kurihara; Yuko Hiruma; Kei Yamana; Laëtitia Michou; Côme Rousseau; Jean Morissette; Deborah L. Galson; Jumpei Teramachi; Hua Zhou; David W. Dempster; et al.

  Contributions of the measles virus nucleocapsid gene and the SQSTM1/p62^P392L mutation to paget's disease

  Cell Metabolism. 2011;13(1):23-34.
  22

• 12.

  2011

  Hisako Ishizuka; Verõnica García-Palacios; Ganwei Lu; Mark A Subler; Heju Zhang; Christina S Boykin; Sun Jin Choi; Liena Zhao; Kenneth Patrene; Deborah L Galson; et al.

  ADAM8 enhances osteoclast precursor fusion and osteoclast formation in vitro and in vivo

  Journal of Bone and Mineral Research. 2011;26(1):169-181.
  5

• 13.

  2011

  Younghun Jung; Yusuke Shiozawa; Jingcheng Wang; Lalit R. Patel; Aaron M. Havens; Junhui Song; Paul H. Krebsbach; G. David Roodman; Russell S. Taichman

  Annexin-2 is a regulator of stromal cell-derived factor-1/CXCL12 function in the hematopoietic stem cell endosteal niche

  Experimental Hematology. 2011;39(2):151-166.e1.
  5

• 14.

  2011

  Noopur Raje; G. David Roodman

  Advances in the biology and treatment of bone disease in multiple myeloma

  Clinical Cancer Research. 2011;17(6):1278-1286.
  25

• 15.

  2011

  Beata Holkova; E. Brent Perkins; Viswanathan Ramakrishnan; Mary Beth Tombes; Ellen Shrader; Neha Talreja; Martha D. Wellons; Kevin T. Hogan; G. David Roodman; Domenico Coppola; et al.

  Phase I trial of bortezomib (PS-341; NSC 681239) and alvocidib (flavopiridol; NSC 649890) in patients with recurrent or refractory B-cell neoplasms

  Clinical Cancer Research. 2011;17(10):3388-3397.
  8

• 16.

  2011

  Rebecca Silbermann; G. David Roodman

  Bone effects of cancer therapies: Pros and cons

  Current Opinion in Supportive and Palliative Care. 2011;5(3):251-257.
  1

• 17.

  2011

  Feng-Ming Wang; Deborah L. Galson; G. David Roodman; Hongjiao Ouyang

  Resveratrol triggers the pro-apoptotic endoplasmic reticulum stress response and represses pro-survival xbp1 signaling in human multiple myeloma cells

  Experimental Hematology. 2011;39(10):999-1006.
  6

• 18.

  2011

  Sonia D'Souza; Davide Del Prete; Shunqian Jin; Quanhong Sun; Alissa J. Huston; Flavia Esteve Kostov; Benedicte Sammut; Chang-Sook Hong; Judith L. Anderson; Kenneth D. Patrene; et al.

  Gfi1 expressed in bone marrow stromal cells is a novel osteoblast suppressor in patients with multiple myeloma bone disease

  Blood. 2011;118(26):6871-6880.
  2

• 19.

  2010

  Michal T. Krauze; G. David Roodman

  Bortezomib and osteoclasts and osteoblasts

  Milestones in Drug Therapy. 2010:43-52.
  0

• 20.

  2010

  E. Terpos; M.A. Dimopoulos; O. Sezer; D. Roodman; N. Abildgaard; R. Vescio; P. Tosi; R. Garcia-Sanz; F. Davies; A. Chanan-Khan; et al.

  The use of biochemical markers of bone remodeling in multiple myeloma: A report of the International Myeloma Working Group

  Leukemia. 2010;24(10):1700-1712.
  10

• 21.

  2010

  Ken Maes; Elizabeta Nemeth; G. David Roodman; Alissa Huston; Flavia Esteve; Cesar Freytes; Natalie Callander; Eirini Katodritou; Lisa Tussing-Humphreys; Seth Rivera; et al.

  In anemia of multiple myeloma, hepcidin is induced by increased bone morphogenetic protein 2

  Blood. 2010;116(18):3635-3644.
  24

• 22.

  2010

  Kimberly Noonan; Luigi Marchionni; Judy Anderson; Drew Pardoll; G. David Roodman; Ivan Borrello

  A novel role of IL-17-producing lymphocytes in mediating lytic bone disease in multiple myeloma

  Blood. 2010;116(18):3554-3563.
  16

• 23.

  2010

  Robert E. Coleman; Allan Lipton; G. David Roodman; Theresa A. Guise; Brendon F. Boyce; Adam M. Brufsky; Philippe Clézardin; Peter I. Croucher; Julie R. Gralow; Peyman Hadji; et al.

  Metastasis and bone loss: Advancing treatment and prevention

  Cancer Treatment Reviews. 2010;36(8):615-620.
  23

• 24.

  2010

  G. David Roodman

  Pathogenesis of myeloma bone disease

  Journal of Cellular Biochemistry. 2010;109(2):283-291.
  15

• 25.

  2010

  Frank C. Cackowski; Judith L. Anderson; Kenneth D. Patrene; Rushir J. Choksi; Steven D. Shapiro; Jolene J. Windle; Harry C. Blair; G. David Roodman

  Osteoclasts are important for bone angiogenesis

  Blood. 2010;115(1):140-149.
  23

• 26.

  2010

  Rekha Pal; Sara A. Monaghan; Andrea Cortese Hassett; Markus Y. Mapara; Peter Schafer; G. David Roodman; Margaret V. Ragni; Lynn Moscinski; Alan List; Suzanne Lentzsch

  Immunomodulatory derivatives induce PU.1 down-regulation, myeloid maturation arrest, and neutropenia

  Blood. 2010;115(3):605-614.
  16

• 27.

  2010

  G. David Roodman

  Insights into the pathogenesis of Paget's disease

  Annals of the New York Academy of Sciences. 2010;1192:176-180.
  13

• 28.

  2010

  James R. Berenson; Kenneth C. Anderson; Robert A. Audell; Ralph V. Boccia; Morton Coleman; Meletios A. Dimopoulos; Matthew T. Drake; Rafael Fonseca; Jean-Luc Harousseau; Douglas Joshua; et al.

  Monoclonal gammopathy of undetermined significance: A consensus statement: Guideline

  British Journal of Haematology. 2010;150(1):28-38.
  18

• 29.

  2010

  Tanya Dossa; Alice Arabian; Jolene J. Windle; Shoukat Dedhar; Steven L. Teitelbaum; F. Patrick Ross; G. David Roodman; René St-Arnaud

  Osteoclast-specific inactivation of the integrin-linked kinase (ILK) inhibits bone resorption

  Journal of Cellular Biochemistry. 2010;110(4):960-967.
  5

• 30.

  2010

  Huiling Cao; Shibing Yu; Zhi Yao; Deborah L. Galson; Yu Jiang; Xiaoyan Zhang; Jie Fan; Binfeng Lu; Youfei Guan; Min Luo; et al.

  Activating transcription factor 4 regulates osteoclast differentiation in mice

  Journal of Clinical Investigation. 2010;120(8):2755-2766.
  9

• 31.

  2010

  G. David Roodman

  Targeting the bone microenvironment in multiple myeloma

  Journal of Bone and Mineral Metabolism. 2010;28(3):244-250.
  8

• 32.

  2009

  G.D. Roodman

  Pathogenesis of myeloma bone disease

  Leukemia. 2009;23(3):435-441.
  70

• 33.

  2009

  Jessica Levy; David R. Roodman

  The role of bisphosphonates in multiple myeloma

  Current Hematologic Malignancy Reports. 2009;4(2):108-112.
  5

• 34.

  2009

  G. David Roodman

  Osteoclasts Pump Iron

  Cell Metabolism. 2009;9(5):405-406.
  0

• 35.

  2009

  Yuko Hiruma; Tadashi Honjo; Diane F. Jelinek; Jolene J. Windle; Jaekyoon Shin; G. David Roodman; Noriyoshi Kurihara

  Increased signaling through p62 in the marrow microenvironment increases myeloma cell growth and osteoclast formation

  Blood. 2009;113(20):4894-4902.
  15

• 36.

  2009

  S.J. Choi; G.D. Roodman; J.Q. Feng; I.S. Song; K. Amin; P.S. Hart; J.T. Wright; N. Haruyama; T.C. Hart

  In vivo impact of a 4 bp deletion mutation in the DLX3 gene on bone development

  Developmental Biology. 2009;325(1):129-137.
  6

• 37.

  2009

  Shibing Yu; Renny T. Franceschi; Min Luo; Jie Fan; Di Jiang; Huiling Cao; Tae-Geon Kwon; Yumei Lai; Jian Zhang; Kenneth Patrene; et al.

  Critical role of activating transcription factor 4 in the anabolic actions of parathyroid hormone in bone

  PLoS ONE. 2009;4(10).
  21

• 38.

  2009

  Rekha Pal; Martin Janz; Deborah L. Galson; Margarete Gries; Shirong Li; Korinna Jöhrens; Ioannis Anagnostopoulos; Bernd Dörken; Markus Y. Mapara; Lisa Borghesi; et al.

  C/EBPβ regulates transcription factors critical for proliferation and survival of multiple myeloma cells

  Blood. 2009;114(18):3890-3898.
  17

• 39.

  2009

  Allan Lipton; Robert Uzzo; Robert J. Amato; Georgiana K. Ellis; Behrooz Hakimian; G. David Roodman; Matthew R. Smith

  The science and practice of bone health in oncology: Managing bone loss and metastasis in patients with solid tumors

  JNCCN Journal of the National Comprehensive Cancer Network. 2009;7(SUPPL. 7):S1-S29.
  10

• 40.

  2009

  Allan Lipton; Gordon A Brown; Gregory R Mundy; G David Roodman; Matthew R Smith

  New opportunities for the management of cancer-related bone complications.

  Clinical advances in hematology & oncology : H&O. 2009;7(5 Suppl 11):1-30; quiz 31.
  0

• 41.

  2008

  Robert E. Coleman; Theresa A. Guise; Allan Lipton; G. David Roodman; James R. Berenson; Jean-Jacques Body; Brendan F. Boyce; Laura M. Calvi; Peyman Hadji; Eugene V. McCloskey; et al.

  Advancing treatment for metastatic bone cancer: Consensus recommendations from the second cambridge conference

  Clinical Cancer Research. 2008;14(20):6387-6395.
  28

• 42.

  2008

  G David Roodman

  Skeletal imaging and management of bone disease.

  Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2008:313-319.
  14

• 43.

  2008

  M.A. Hussein; F.D. Vrionis; R. Allison; J. Berenson; S. Berven; E. Erdem; S. Giralt; S. Jagannath; R.A. Kyle; S. LeGrand; et al.

  Erratum: The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement (Leukemia (2008) 101038/leu.2008.127)

  Leukemia. 2008;22(8):1649.
  0

• 44.

  2008

  M.A. Hussein; F.D. Vrionis; R. Allison; J. Berenson; S. Berven; E. Erdem; S. Giralt; S. Jagannath; R.A. Kyle; S. LeGrand; et al.

  The role of vertebral augmentation in multiple myeloma: International Myeloma Working Group Consensus Statement

  Leukemia. 2008;22(8):1479-1484.
  18

• 45.

  2008

  Sanjai Sharma; Elizabeta Nemeth; Yi-Hsiang Chen; Julia Goodnough; Alissa Huston; G.D. Roodman; Tomas Ganz; Alan Lichtenstein

  Involvement of hepcidin in the anemia of multiple myeloma

  Clinical Cancer Research. 2008;14(11):3262-3267.
  32

• 46.

  2008

  Yusuke Shiozawa; Aaron M. Havens; Younghun Jung; Anne M. Ziegler; Elisabeth A. Pedersen; Jingcheng Wang; Jianhua Wang; Ganwei Lu; G. David Roodman; Robert D. Loberg; et al.

  Annexin II/annexin II receptor axis regulates adhesion, migration, homing, and growth of prostate cancer

  Journal of Cellular Biochemistry. 2008;105(2):370-380.
  48

• 47.

  2008

  Yuko Hiruma; Noriyoshi Kurihara; Mark A. Subler; Hua Zhou; Christina S. Boykin; Heju Zhang; Seiichi Ishizuka; David W. Dempster; G. David Roodman; Jolene J. Windle

  A SQSTM1/p62 mutation linked to Paget's disease increases the osteoclastogenic potential of the bone microenvironment

  Human Molecular Genetics. 2008;17(23):3708-3719.
  28

• 48.

  2008

  G. David Roodman

  Novel targets for myeloma bone disease

  Expert Opinion on Therapeutic Targets. 2008;12(11):1377-1387.
  11

• 49.

  2008

  G. David Roodman; William C. Dougall

  RANK ligand as a therapeutic target for bone metastases and multiple myeloma

  Cancer Treatment Reviews. 2008;34(1):92-101.
  47

• 50.

  2008

  G. David Roodman

  Bone building with bortezomib

  Journal of Clinical Investigation. 2008;118(2):462-464.
  19

• 51.

  2008

  Alissa Huston; Xavier Leleu; Xiaoying Jia; Anne-Sophie Moreau; Hai T. Ngo; Judith Runnels; Judy Anderson; Yazan Alsayed; Aldo Roccaro; Sonia Vallet; et al.

  Targeting Akt and heat shock protein 90 produces synergistic multiple myeloma cell cytotoxicity in the bone marrow microenvironment

  Clinical Cancer Research. 2008;14(3):865-874.
  29

• 52.

  2008

  Seiichi Ishizuka; Noriyoshi Kurihara; Yuko Hiruma; Daishiro Miura; Jun-ichi Namekawa; Azusa Tamura; Yuko Kato-Nakamura; Yusuke Nakano; Kazuya Takenouchi; Yuichi Hashimoto; et al.

  1α,25-Dihydroxyvitamin D₃-26,23-lactam analogues function as vitamin D receptor antagonists in human and rodent cells

  Journal of Steroid Biochemistry and Molecular Biology. 2008;110(3-5):269-277.
  3

• 53.

  2007

  Robert A. Kyle; Gary C. Yee; Mark R. Somerfield; Patrick J. Flynn; Susan Halabi; Sundar Jagannath; Robert Z. Orlowski; David G. Roodman; Patricia Twilde; Kenneth Anderson

  ASCO 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma: Guideline summary

  Journal of Oncology Practice. 2007;3(4):236.
  1

• 54.

  2007

  Yi Lu; Zhong Cai; Guozhi Xiao; Evan T. Keller; Atsushi Mizokami; Zhi Yao; G. David Roodman; Jian Zhang

  Monocyte chemotactic protein-1 mediates prostate cancer-induced bone resorption

  Cancer Research. 2007;67(8):3646-3653.
  66

• 55.

  2007

  Robert A. Kyle; Gary C. Yee; Mark R. Somerfield; Patrick J. Flynn; Susan Halabi; Sundar Jagannath; Robert Z. Orlowski; David G. Roodman; Patricia Twilde; Kenneth Anderson

  American society of clinical oncology 2007 clinical practice guideline update on the role of bisphosphonates in multiple myeloma

  Journal of Clinical Oncology. 2007;25(17):2464-2472.
  195

• 56.

  2007

  Suzanne Lentzsch; Gary Elliott; G. David Roodman

  SDX-308 and SDX-101, non-steroidal anti-inflammatory drugs, as therapeutic candidates for treating hematologic malignancies including myeloma

  Archiv der Pharmazie. 2007;340(10):511-516.
  8

• 57.

  2007

  Suzanne Lentzsch; Lori A. Ehrlich; G. David Roodman

  Pathophysiology of Multiple Myeloma Bone Disease

  Hematology/Oncology Clinics of North America. 2007;21(6):1035-1049.
  21

• 58.

  2007

  Frank C. Cackowski; G. David Roodman

  Perspective on the osteoclast: An angiogenic cell?

  Annals of the New York Academy of Sciences. 2007;1117:12-25.
  8

• 59.

  2007

  G.D. Roodman

  Treatment strategies for bone disease

  Bone Marrow Transplantation. 2007;40(12):1139-1146.
  13

• 60.

  2007

  Flavia R. Esteve; G. David Roodman

  Pathophysiology of myeloma bone disease

  Best Practice and Research: Clinical Haematology. 2007;20(4):613-624.
  37

• 61.

  2007

  Veronica Garcia-Palacios; Ho Yeon Chung; Sun Jin Choi; Aliye Sarmasik; Noriyoshi Kurihara; Jun Won Lee; Deborah L. Galson; Robert Collins; G. David Roodman

  Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing in osteoclast precursors expression of LFA-1 and ICAM-1

  Bone. 2007;40(2):316-322.
  9

• 62.

  2007

  Noriyoshi Kurihara; Yuko Hiruma; Hua Zhou; Mark A. Subler; David W. Dempster; Frederick R. Singer; Sakamuri V. Reddy; Helen E. Gruber; Jolene J. Windle; G. David Roodman

  Mutation of the sequestosome 1 (p62) gene increases osteoclastogenesis but does not induce Paget disease

  Journal of Clinical Investigation. 2007;117(1):133-142.
  50

• 63.

  2007

  G. David Roodman

  Bone-breaking cancer treatment

  Nature Medicine. 2007;13(1):25-26.
  5

• 64.

  2007

  Noriyoshi Kurihara; Hua Zhou; Sakamuri V. Reddy; Veronica Garcia Palacios; Mark A. Subler; David W. Dempster; Jolene J. Windle; G. David Roodman

  Experimental models of Paget's disease

  Journal of Bone and Mineral Research. 2007;22(SUPPL. 2):P55-P57.
  3

• 65.

  2007

  Frederick R. Singer; Barbara G. Mills; Helen E. Gruber; Jolene J. Windle; G. David Roodman

  Ultrastructure of bone cells in Paget's disease of bone

  Journal of Bone and Mineral Research. 2007;22(SUPPL. 2):P51-P54.
  1

• 66.

  2007

  Rentian Feng; Gülsüm Anderson; Guozhi Xiao; Gary Elliott; Lorenzo Leoni; Markus Y. Mapara; G. David Roodman; Suzanne Lentzsch

  SDX-308, a nonsteroidal anti-inflammatory agent, inhibits NF-κB activity, resulting in strong inhibition of osteoclast formation/activity and multiple myeloma cell growth

  Blood. 2007;109(5):2130-2138.
  32

• 67.

  2007

  Yazan Alsayed; Hai Ngo; Judith Runnels; Xavier Leleu; Ujjal K. Singha; Costas M. Pitsillides; Joel A. Spencer; Teresa Kimlinger; Joanna M. Ghobrial; Xiaoying Jia; et al.

  Mechanisms of regulation of CXCR4/SDF-1 (CXCL12)-dependent migration and homing in multiple myeloma

  Blood. 2007;109(7):2708-2717.
  140

• 68.

  2006

  Noriyoshi Kurihara; Hua Zhou; Sakamuri V. Reddy; Veronica Garcia Palacios; Mark A. Subler; David W. Dempster; Jolene J. Windle; G David Roodman

  Experimental models of Paget's disease

  Journal of Bone and Mineral Research. 2006;21(SUPPL. 2):P55-P57.
  5

• 69.

  2006

  Frederick R. Singer; Barbara G. Mills; Helen E. Gruber; Jolene J. Windle; G David Roodman

  Ultrastructure of bone cells in Paget's disease of bone

  Journal of Bone and Mineral Research. 2006;21(SUPPL. 2):P51-P54.
  1

• 70.

  2006

  Rohit Aggarwal; Irene M. Ghobrial; G. David Roodman

  Chemokines in multiple myeloma

  Experimental Hematology. 2006;34(10):1289-1295.
  54

• 71.

  2006

  Hongwei Rao; Ganwei Lu; Hiroshi Kajiya; Veronica Garcia-Palacios; Noriyoshi Kurihara; Judy Anderson; Ken Patrene; Dean Sheppard; Harry C. Blair; Jolene J. Windle; et al.

  α₉β₁: A novel osteoclast integrin that regulates osteoclast formation and function

  Journal of Bone and Mineral Research. 2006;21(10):1657-1665.
  32

• 72.

  2006

  Ganwei Lu; Hidefumi Maeda; Sakamuri V. Reddy; Noriyoshi Kurihara; Robin Leach; Judith L. Anderson; G. David Roodman

  Cloning and characterization of the annexin II receptor on human marrow stromal cells

  Journal of Biological Chemistry. 2006;281(41):30542-30550.
  13

• 73.

  2006

  Noriyoshi Kurihara; Hua Zhou; Sakamuri V. Reddy; Veronica Garcia Palacios; Mark A. Subler; David W. Dempster; Jolene J. Windle; G. David Roodman

  Expression of measles virus nucleocapsid protein in osteoclasts induces Paget's disease-like bone lesions in mice

  Journal of Bone and Mineral Research. 2006;21(3):446-455.
  49

• 74.

  2006

  Gülsüm Anderson; Margarete Gries; Noriyoshi Kurihara; Tadashi Honjo; Judy Anderson; Vera Donnenberg; Albert Donnenberg; Irene Ghobrial; Markus Y. Mapara; David Stirling; et al.

  Thalidomide derivative CC-4047 inhibits osteoclast formation by down-regulation of PU.1

  Blood. 2006;107(8):3098-3105.
  63

• 75.

  2006

  Aaron N. Nguyen; Elizabeth G. Stebbins; Margaret Henson; Gilbert O'Young; Sun J. Choi; Diana Quon; Debby Damm; Mamatha Reddy; Jing Y. Ma; Edwin Haghnazari; et al.

  Normalizing the bone marrow microenvironment with p38 inhibitor reduces multiple myeloma cell proliferation and adhesion and suppresses osteoclast formation

  Experimental Cell Research. 2006;312(10):1909-1923.
  30

• 76.

  2006

  Veronica Garcia Palacios; Ho Yeon Chung; Sun Jin Choi; Noriyoshi Kurihara; Jun Won Lee; Lori A. Ehrlich; Robert Collins; G. David Roodman

  Eosinophil chemotactic factor-L (ECF-L) enhances osteoclast formation by increasing ICAM-1 expression

  Annals of the New York Academy of Sciences. 2006;1068(1):240-243.
  0

• 77.

  2006

  G. David Roodman

  Regulation of osteoclast differentiation

  Annals of the New York Academy of Sciences. 2006;1068(1):100-109.
  86

• 78.

  2006

  Alissa Huston; G. David Roodman

  Role of the microenvironment in multiple myeloma bone disease

  Future Oncology. 2006;2(3):371-378.
  6

• 79.

  2006

  Allan Lipton; James R. Berenson; Jean-Jacques Body; Brendan F. Boyce; Oyvind S. Bruland; Michael A. Carducci; Charles S. Cleeland; Denis R. Clohisy; Robert E. Coleman; Richard J. Cook; et al.

  Advances in treating metastatic bone cancer: Summary statement for the First Cambridge Conference

  Clinical Cancer Research. 2006;12(20 PART 2):6209s-6212s.
  3

• 80.

  2006

  G. David Roodman; Berenson; Clohisy; Bruland; Suva; Weilbaecher

  New potential targets for treating myeloma bone disease

  Clinical Cancer Research. 2006;12(20 PART 2):6270s-6273s.
  19

• 81.

  2006

  G. Kesava Reddy; Tariq I. Mughal; G. David Roodman

  Novel approaches in the management of myeloma-related skeletal complications

  Supportive Cancer Therapy. 2006;4(1):15-18.
  5

• 82.

  2006

  Nicola Giuliani; Vittorio Rizzoli; G. David Roodman

  Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition

  Blood. 2006;108(13):3992-3996.
  99

• 83.

  2006

  Esther Masih-Khan; Suzanne Trudel; Carla Heise; Zhihua Li; Joshua Paterson; Vincent Nadeem; Ellen Wei; David Roodman; Jaime O. Claudio; P. Leif Bergsagel; et al.

  MIP-1α (CCL3) is a downstream target of FGFR3 and RAS-MAPK signaling in multiple myeloma

  Blood. 2006;108(10):3465-3471.
  32

• 84.

  2006

  Alissa Huston; Jason Brown; G. David Roodman

  Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma

  Experimental Hematology. 2006;34(12):1616.
  4

• 85.

  2006

  Lanie K. Francis; Yazan Alsayed; Xavier Leleu; Xiaoying Jia; Ujjal K. Singha; Judith Anderson; Michael Timm; Hai Ngo; Ganwei Lu; Alissa Huston; et al.

  Combination mammalian target of rapamycin inhibitor rapamycin and HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin has synergistic activity in multiple myeloma

  Clinical Cancer Research. 2006;12(22):6826-6835.
  51

• 86.

  2005

  G. David Roodman

  High bone turnover markers predict poor outcome in patients with bone metastasis

  Journal of Clinical Oncology. 2005;23(22):4821-4822.
  9

• 87.

  2005

  Yasuo Oba; Jun Won Lee; Lori A. Ehrlich; Ho Yeon Chung; Diane F. Jelinek; Natalie S. Callander; Richard Horuk; Sun Jin Choi; G. David Roodman

  MIP-1α utilizes both CCR1 and CCR5 to induce osteoclast formation and increase adhesion of myeloma cells to marrow stromal cells

  Experimental Hematology. 2005;33(3):272-278.
  62

• 88.

  2005

  G. David Roodman; Jolene J. Windle

  Paget disease of bone

  Journal of Clinical Investigation. 2005;115(2):200-208.
  144

• 89.

  2005

  Seiichi Ishizuka; Noriyoshi Kurihara; Sakamuri V. Reddy; Julian Cornish; Tim Gundy; G. David Roodman

  (23S)-25-dehydro-1α-hydroxyvitamin D₃-26,23-lactone, a vitamin D receptor antagonist that inhibits osteoclast formation and bone resorption in bone marrow cultures front patients with Paget's disease

  Endocrinology. 2005;146(4):2023-2030.
  20

• 90.

  2005

  Raghavendra Vasudeva Murthy; Gunnar Arbman; Jingfang Gao; G. David Roodman; Xiao-Feng Sun

  Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer

  Clinical Cancer Research. 2005;11(6):2293-2299.
  28

• 91.

  2005

  Fanghong Li; Ho Yeon Chung; Sakamuri V. Reddy; Ganwei Lu; Noriyoshi Kurihara; Allan Z. Zhao; G. David Roodman

  Annexin II stimulates RANKL expression through MAPK

  Journal of Bone and Mineral Research. 2005;20(7):1161-1167.
  23

• 92.

  2005

  Lori A. Ehrlich; Ho Yeon Chung; Irene Ghobrial; Sun Jin Choi; Francesca Morandi; Simona Colla; Vittorio Rizzoli; G. David Roodman; Nicola Giuliani

  EL-3 is a potential inhibitor of osteoblast differentiation in multiple myeloma

  Blood. 2005;106(4):1407-1414.
  83

• 93.

  2005

  G. David Roodman

  Myeloma bone disease: Pathogenesis and treatment. From the Multiple Myeloma Research Foundation

  ONCOLOGY. 2005;19(8):983-986.
  5

• 94.

  2005

  Lori A. Ehrlich; G. David Roodman

  The role of immune cells and inflammatory cytokines in Paget's disease and multiple myeloma

  Immunological Reviews. 2005;208:252-266.
  33

• 95.

  2004

  Noriyoshi Kurihara; Sakamuri V. Reddy; Norie Araki; Seiichi Ishizuka; Keiichi Ozono; Jillian Cornish; Tim Cundy; Frederick R. Singer; G. David Roodman

  Role of TAF_II-17, a VDR binding protein, in the increased osteoclast formation in Paget's disease

  Journal of Bone and Mineral Research. 2004;19(7):1154-1164.
  31

• 96.

  2004

  Seiichi Ishizuka; Noriyoshi Kurihara; Daishiro Miura; Kazuya Takenouchi; Jillian Cornish; Tim Cundy; Sakamuri V. Reddy; G. David Roodman

  Vitamin D antagonist, TEI-9647, inhibits osteoclast formation induced by 1α,25-dihydroxyvitamin D₃ from pagetic bone marrow cells

  Journal of Steroid Biochemistry and Molecular Biology. 2004;89-90:331-334.
  18

• 97.

  2004

  Ferris M. Hall; G. David Roodman

  Bone metastasis [5] (multiple letters)

  New England Journal of Medicine. 2004;351(2):195-196.
  1

• 98.

  2004

  Brian G.M. Durie; Robert A. Kyle; Andrew Belch; William Bensinger; Joan Blade; Mario Boccadoro; J. Anthony Child; Raymond Comenzo; Ben Djulbegovic; Dorotea Fantl; et al.

  Erratum: Myeloma management guidelines: A consensus report from the scientific advisors of the international myeloma foundation (The Hematology Journal (2003) vol, 4 (379-398) 10.1038/sj.thj.6200312)

  Hematology Journal. 2004;5(3):285.
  7

• 99.

  2004

  G. David Roodman

  Mechanisms of Bone Metastasis

  New England Journal of Medicine. 2004;350(16):1655-1664+1698.
  700

• 100.

  2004

  Jennifer L. Roccisana; Noriaki Kawanabe; Hiroshi Kajiya; Masanori Koide; G. David Roodman; Sakamuri V. Reddy

  Functional Role for Heat Shock Factors in the Transcriptional Regulation of Human RANK Ligand Gene Expression in Stromal/Osteoblast Cells

  Journal of Biological Chemistry. 2004;279(11):10500-10507.
  23

• 101.

  2004

  Jun Won Lee; Ho Yeon Chung; Lori A. Ehrlich; Diane F. Jelinek; Natalie S. Callander; G. David Roodman; Sun Jin Choi

  IL-3 expression by myeloma cells increases both osteoclast formation and growth of myeloma cells

  Blood. 2004;103(6):2308-2315.
  83

• 102.

  2004

  G. David Roodman

  Pathogenesis of myeloma bone disease

  Blood Cells, Molecules, and Diseases. 2004;32(2):290-292.
  64

• 103.

  2004

  G. David Roodman

  Erratum: Pathogenesis of myeloma bone disease (Blood Cells, Molecules, and Diseases (2004) 32 (290-292) DOI: 10.1016/j.bcmd.2004.01.001)

  Blood Cells, Molecules, and Diseases. 2004;33(1):95.
  0

• 104.

  2004

  Noriyoshi Kurihara; Seiichi Ishizuka; Anne Demulder; Cheikh Menaa; G. David Roodman

  Paget's disease - A VDR coactivator disease?

  Journal of Steroid Biochemistry and Molecular Biology. 2004;89-90:321-325.
  12

• 105.

  2003

  G. David Roodman

  Mechanisms of bone resorption in myeloma

  Journal of Musculoskeletal Neuronal Interactions. 2003;3(4):271-272.
  3

• 106.

  2003

  G. David Roodman

  Summary - Bone resorption session

  Journal of Musculoskeletal Neuronal Interactions. 2003;3(4):292-294.
  0

• 107.

  2003

  G. David Roodman

  Introduction - Control of bone resorption: Six different topics related to osteoclast activity

  Journal of Musculoskeletal Neuronal Interactions. 2003;3(4):270.
  0

• 108.

  2003

  G. David Roodman

  Recent developments in Paget's disease

  Advanced Studies in Medicine. 2003;3(5):286-292.
  1

• 109.

  2003

  Robert A. Kyle; J. Anthony Child; Kenneth Anderson; Bart Barlogie; Regis Bataille; William Bensinger; Joan Bladé; Mario Boccadoro; William Dalton; Meletios Dimopoulos; et al.

  Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: A report of the International Myeloma Working Group

  British Journal of Haematology. 2003;121(5):749-757.
  786

• 110.

  2003

  A Hari Reddi; David Roodman; Colette Freeman; Suresh Mohla

  Mechanisms of tumor metastasis to the bone: Challenges and opportunities

  Journal of Bone and Mineral Research. 2003;18(2):190-194.
  57

• 111.

  2003

  G. David Roodman

  Role of stromal-derived cytokines and growth factors in bone metastasis

  Cancer. 2003;97(3 SUPPL.):733-738.
  38

• 112.

  2003

  Yasuo Oba; Ho Yeon Chung; Sun Jin Choi; G. David Roodman

  Eosinophil Chemotactic Factor-L (ECF-L): A Novel Osteoclast Stimulating Factor

  Journal of Bone and Mineral Research. 2003;18(7):1332-1341.
  14

• 113.

  2003

  Sun J. Choi; Tomoko Oba; Natalie S. Callander; Diane F. Jelinek; G. David Roodman

  AML-1A and AML-1B regulation of MIP-1α expression in multiple myeloma

  Blood. 2003;101(10):3778-3783.
  27

• 114.

  2003

  Brian G.M. Durie; Robert A. Kyle; Andrew Belch; William Bensinger; Joan Blade; Mario Boccadoro; J. Anthony Child; Raymond Comenzo; Ben Djulbegovic; Dorotea Fantl; et al.

  Myeloma management guidelines: A consensus report from the Scientific Advisors of the International Myeloma Foundation

  Hematology Journal. 2003;4(6):379-398.
  217

• 115.

  2002

  Kenneth C Anderson; John D Shaughnessy Jr.; Bart Barlogie; Jean-Luc Harousseau; G David Roodman

  Multiple myeloma.

  Hematology / the Education Program of the American Society of Hematology. American Society of Hematology. Education Program. 2002:214-240.
  48

• 116.

  2002

  W.E. Friedrichs; S.V. Reddy; J.M. Bruder; T. Cundy; J. Cornish; F.R. Singer; G.D. Roodman

  Sequence analysis of measles virus nucleocapsid transcripts in patients with Paget's disease

  Journal of Bone and Mineral Research. 2002;17(1):145-151.
  58

• 117.

  2002

  O. Sezer; U. Heider; C. Jakob; J. Eucker; K. Possinger; G.D. Roodman

  Human bone marrow myeloma cells express RANKL [2] (multiple letters)

  Journal of Clinical Oncology. 2002;20(1):353-354.
  61

• 118.

  2002

  Christian Darimont; Ornella Avanti; Yvonne Tromvoukis; Patricia Vautravers-Leone; Nori Kurihara; G. David Roodman; Lorel M. Colgin; Heide Tullberg-Reinert; Andrea M.A. Pfeifer; Elizabeth A. Offord; et al.

  SV40 T antigen and telomerase are required to obtain immortalized human adult bone cells without loss of the differentiated phenotype

  Cell Growth and Differentiation. 2002;13(2):59-67.
  17

• 119.

  2002

  G. David Roodman

  Role of the bone marrow microenvironment in multiple myeloma

  Journal of Bone and Mineral Research. 2002;17(11):1921-1925.
  71

• 120.

  2002

  Bert K. Rima; Uta Gassen; Miep H. Helfrich; Stuart H. Ralston; William E. Friedrichs; Sakamuri V. Reddy; Frederick J. Singer; G. David Roodman

  The pro and con of measles virus in Paget's disease: Con (multiple letters)

  Journal of Bone and Mineral Research. 2002;17(12):2290-2293.
  23

• 121.

  2001

  S.J. Choi; N. Kurihara; Y. Oba; G.D. Roodman

  Osteoclast inhibitory peptide 2 inhibits osteoclast formation via its c-terminal fragment

  Journal of Bone and Mineral Research. 2001;16(10):1804-1811.
  19

• 122.

  2001

  G.David Roodman

  Studies in Paget's disease and their relevance to oncology

  Seminars in Oncology. 2001;28(4 SUPPL. 11):15-21.
  16

• 123.

  2001

  Natalie S Callander; G.David Roodman

  Myeloma bone disease

  Seminars in Hematology. 2001;38(3):276-285.
  92

• 124.

  2001

  Sakamuri V. Reddy; Noriyoshi Kurihara; Cheikh Menaa; Gary Landucci; Donald Forthal; Barbara A. Koop; Jolene J. Windle; G. David Roodman

  Osteoclasts formed by measles virus-infected osteoclast precursors from hCD46 transgenic mice express characteristics of pagetic osteoclasts

  Endocrinology. 2001;142(7):2898-2905.
  51

• 125.

  2001

  Jose C Cruz; Melissa Alsina; Fiona Craig; Toshiyuki Yoneda; Judith L Anderson; Mark Dallas; G.David Roodman

  Ibandronate decreases bone disease development and osteoclast stimulatory activity in an in vivo model of human myeloma

  Experimental Hematology. 2001;29(4):441-447.
  35

• 126.

  2001

  Sun Jin Choi; J.-H. Han; G.D. Roodman

  ADAM8: A novel osteoclast stimulating factor

  Journal of Bone and Mineral Research. 2001;16(5):814-822.
  68

• 127.

  2001

  Robin J. Leach; Frederick R. Singer; G. David Roodman

  Genetics of endocrine disease: The genetics of paget's disease of the bone

  Journal of Clinical Endocrinology and Metabolism. 2001;86(1):24-28.
  31

• 128.

  2001

  Sakamuri V. Reddy; Noriyoshi Kurihara; Cheikh Menaa; G. David Roodman

  Paget's Disease of Bone: A Disease of the Osteoclast

  Reviews in Endocrine and Metabolic Disorders. 2001;2(2):195-201.
  30

• 129.

  2001

  Je-Ho Man; Sun Jin Choi; Noriyoshi Kurihara; Masanori Koide; Yasuo Oba; G. David Roodman

  Macrophage inflammatory protein-1α is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor κB ligand

  Blood. 2001;97(11):3349-3353.
  160

• 130.

  2001

  G.D. Roodman

  Biology of osteoclast activation in cancer

  Journal of Clinical Oncology. 2001;19(15):3562-3571.
  167

• 131.

  2001

  Sun Jin Choi; Yasuo Oba; Yair Gazitt; Melissa Alsina; Jose Cruz; Judith Anderson; G. David Roodman

  Antisense inhibition of macrophage inflammatory protein 1-α blocks bone destruction in a model of myeloma bone disease

  Journal of Clinical Investigation. 2001;108(12):1833-1841.
  133

• 132.

  2001

  Y. Gazitt; D. Roodman; C. Freytes; P. Shaughnessy; N. Callander; A. Traynor; M. Rothenberg

  A phase I-II clinical trial with a combination of gemcitabine (GEMZAR) and paclitaxel (TAXOL) for the treatment of refractory multiple myeloma (MM) patients

  Blood. 2001;96(11 PART II):287b.
  3

• 133.

  2001

  N.S. Callander; J. Galvez; R. Cortes; M. Aisina; G.D. Roodman

  Clinical presentation of hispanic (H) patients (PTS) with multiple myeloma (MM) in bexar county (BC), Texas

  Blood. 2001;96(11 PART II):271b.
  0

• 134.

  2001

  Madhav V. Dhodapkar; Joth L. Jacobson; Morie A. Gertz; Saul E. Rivkin; G. David Roodman; Joseph M. Tuscano; Muhammad Shurafa; Robert A. Kyle; John J. Crowley; Bart Barlogie

  Prognostic factors and response to fludarabine therapy in patients with Waldenström macroglobulinemia: Results of United States intergroup trial (Southwest Oncology Group S9003)

  Blood. 2001;98(1):41-48.
  89

• 135.

  2000

  Sun Young Rha; Elzbieta Izbicka; Richard Lawrence; Karen Davidson; Daekyu Sun; Mary Pat Moyer; G. David Roodman; Lawrence Hurley; Daniel Von Hoff

  Effect of telomere and telomerase interactive agents on human tumor and normal cell lines

  Clinical Cancer Research. 2000;6(3):987-993.
  43

• 136.

  2000

  M.P. Whyte; B.G. Mills; W.R. Reinus; M.N. Podgornik; G.D. Roodman; F.H. Gannon; M.C. Eddy; W.H. McAlister

  Expansile skeletal hyperphosphatasia: A new familial metabolic bone disease

  Journal of Bone and Mineral Research. 2000;15(12):2330-2344.
  40

• 137.

  2000

  Cheikh Menaa; Sakamuri V. Reddy; Noriyoshi Kurihara; Hidefumi Maeda; Dirk Anderson; Tim Cundy; Jillian Cornish; Frederick R. Singer; Jan M. Bruder; G. David Roodman

  Enhanced RANK ligand expression and responsivity of bone marrow cells in Paget's disease of bone

  Journal of Clinical Investigation. 2000;105(12):1833-1838.
  95

• 138.

  2000

  T.A. Hentunen; S.J. Choi; B.F. Boyce; M.R. Dallas; S.L. Dallas; G.L. Shen-Ong; G.D. Roodman

  A murine model of inflammatory bone disease

  Bone. 2000;26(2):183-188.
  16

• 139.

  2000

  Cheikh Menaa; Julia Barsony; Sakamuri V. Reddy; Jillian Cornish; Tim Cundy; G. David Roodman

  1,25-dihydroxyvitamin D₃ hypersensitivity of osteoclast precursors from patients with Paget's disease

  Journal of Bone and Mineral Research. 2000;15(2):228-236.
  55

• 140.

  2000

  R. Schaub; B. Dupont; G.D. Roodman; R.J. Leach; S.V. Reddy

  Assignment of OSTF1 to human chromosome bands 12q24.1 → q24.2 by in situ hybridization

  Cytogenetics and Cell Genetics. 2000;88(1-2):87-88.
  3

• 141.

  2000

  Noriyoshi Kurihara; Sakamuri V. Reddy; Cheikh Menaa; Dirk Anderson; G. David Roodman

  Osteoclasts expressing the measles virus nucleocapsid gene display a pagetic phenotype

  Journal of Clinical Investigation. 2000;105(5):607-614.
  73

• 142.

  2000

  Cheikh Menaa; Noriyoshi Kurihara; G. David Roodman

  CFU-GM-derived cells form osteoclasts at a very high efficiency

  Biochemical and Biophysical Research Communications. 2000;267(3):943-946.
  38

• 143.

  2000

  Sun Jin Choi; Jose C. Cruz; Fiona Craig; Hoyeon Chung; Rowena D. Devlin; G. David Roodman; Melissa Alsina

  Macrophage inflammatory protein 1-alpha is a potential osteoclast stimulatory factor in multiple myeloma

  Blood. 2000;96(2):671-675.
  225

• 144.

  1999

  Jussi M. Halleen; Seija Räisänen; Jari J. Salo; Sakamuri V. Reddy; G. David Roodman; Teuvo A. Hentunen; Petri P. Lehenkari; Helena Kaija; Pirkko Vihko; et al.

  Intracellular fragmentation of bone resorption products by reactive oxygen species generated by osteoclastic tartrate-resistant acid phosphatase

  Journal of Biological Chemistry. 1999;274(33):22907-22910.
  125

• 145.

  1999

  Cheikh Menaa; Rowena D. Devlin; Sakamuri V. Reddy; Yair Gazitt; Sun Jin Choi; G. David Roodman

  Annexin II increases osteoclast formation by stimulating the proliferation of osteoclast precursors in human marrow cultures

  Journal of Clinical Investigation. 1999;103(11):1605-1613.
  57

• 146.

  1999

  G.David Roodman

  Cell biology of the osteoclast

  Experimental Hematology. 1999;27(8):1229-1241.
  286

• 147.

  1999

  Kelly L. Wirfel; Jan M. Bruder; Aizaz Vardag; G. David Roodman

  Osteoclast function in healthy subjects and in patients with Paget's disease

  Endocrinologist. 1999;9(4):263-269.
  0

• 148.

  1999

  Robin J. Leach; Frederick R. Singer; Jannine D. Cody; G. David Roodman

  Variable disease severity associated with a Paget's disease predisposition gene

  Journal of Bone and Mineral Research. 1999;14(SUPPL. 2):17-20.
  15

• 149.

  1999

  Sakamuri V. Reddy; Cheikh Menaa; Frederick R. Singer; Anne Demulder; G. David Roodman

  Cell biology of Paget's disease

  Journal of Bone and Mineral Research. 1999;14(SUPPL. 2):3-8.
  31

• 150.

  1999

  Sakamuri V. Reddy; Cheikh Menaa; Frederick R. Singer; Tim Cundy; Jillian Cornish; Michael P. Whyte; G.David Roodman

  Measles virus nucleocapsid transcript expression is not restricted to the osteoclast lineage in patients with Paget's disease of bone

  Experimental Hematology. 1999;27(10):1528-1532.
  30

• 151.

  1999

  G. David Roodman

  Mechanisms of abnormal bone turnover in Paget's disease

  Bone. 1999;24(5 SUPPL.):39S-40S.
  6

• 152.

  1999

  Teuvo A. Hentunen; Sharon H. Jackson; Hoyeon Chung; Sakamuri V. Reddy; Joseph Lorenzo; Sun Jin Choi; G. David Roodman

  Characterization of immortalized osteoclast precursors developed from mice transgenic for both bcl-X(L) and simian virus 40 large T antigen

  Endocrinology. 1999;140(7):2954-2961.
  17

• 153.

  1999

  Sun Jin Choi; Sakamuri V. Reddy; Rowena D. Devlin; Cheikh Menaa; Hoyeon Chung; Brendan F. Boyce; G. David Roodman

  Identification of human asparaginyl endopeptidase (legumain) as an inhibitor of osteoclast formation and bone resorption

  Journal of Biological Chemistry. 1999;274(39):27747-27753.
  52

• 154.

  1999

  J. Moore; J.A. Anderson; G.D. Roodman; S.V. Reddy

  Effects of alendronate on cytokine production and osteoclast formation induced by human marrow stromal cells

  Journal of Investigative Medicine. 1999;47(2):132A.
  0

• 155.

  1998

  Gabriel Mbalaviele; Riko Nishimura; Akira Myoi; Maria Niewolna; Sakamuri V. Reddy; Di Chen; Jian Feng; David Roodman; Gregory R. Mundy; Toshiyuki Yoneda

  Cadherin-6 mediates the heterotypic interactions between the hemopoietic osteoclast cell lineage and stromal cells in a murine model of osteoclast differentiation

  Journal of Cell Biology. 1998;141(6):1467-1476.
  35

• 156.

  1998

  Julie Roach; Sun Jin Choi; Rebecca L. Schaub; Robin J. Leach; G. David Roodman; Sakamuri V. Reddy

  Further characterization of the murine collagenase (type IVB) gene promoter and analysis of mRNA expression in murine tissues

  Gene. 1998;208(2):117-122.
  6

• 157.

  1998

  G. David Roodman

  Paget's Disease of Bone

  Advances in Organ Biology. 1998;5(C):661-675.
  0

• 158.

  1998

  S.J. Choi; R. Davlin; S.V. Baddy; G.D. Roodman

  Cloning and identification of human stem cell antigen as a novel inhibitor of osteoclast formation and bone resorption

  Experimental Hematology. 1998;26(8):729.
  0

• 159.

  1998

  Shou-Jiang Gao; Melissa Alsina; Jian-Hong Deng; Chantal R. Harrison; Eduardo A. Montalvo; Charles T. Leach; G. David Roodman; Hal B. Jenson

  Antibodies to Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in patients with multiple myeloma

  Journal of Infectious Diseases. 1998;178(3):846-849.
  46

• 160.

  1998

  Sakamuri Reddy; Rowena Devlin; Cheikh Menaa; Riko Nishimura; Sun Jin Choi; Mark Dallas; Toshi Yoneda; G. David Roodman

  Isolation and characterization of a cDNA clone encoding a novel peptide (OSF) that enhances osteoclast formation and bone resorption

  Journal of Cellular Physiology. 1998;177(4):636-645.
  27

• 161.

  1998

  G.D. Roodman

  Osteoclast differentiation and activity

  Biochemical Society Transactions. 1998;26(1):7-13.
  3

• 162.

  1998

  Rowena D. Devlin; Sakamuri V. Reddy; Rocco Savino; Gennaro Ciliberto; G. David Roodman

  IL-6 mediates the effects of IL-1 or TNF, but not PTHrP or 1,25(OH)₂D₃, on osteoclast-like cell formation in normal human bone marrow cultures

  Journal of Bone and Mineral Research. 1998;13(3):393-399.
  43

• 163.

  1998

  D. Sachdev; Y. Ohsaki; G.D. Roodman; J.M. Chirgwin

  Epitope mapping of recombinant human procathepsin D

  Advances in Experimental Medicine and Biology. 1998;436:185-190.
  0

• 164.

  1998

  G.D. Roodman; Y. Ohsaki; M.M. Miller; A. Demulder; D. Hosking; F.R. Singer; L.M. McManus

  Pagetic osteoclasts formed in vitro: Absence of paracrystalline inclusions

  Journal of Submicroscopic Cytology and Pathology. 1998;30(2):315-327.
  2

• 165.

  1998

  Teuvo A. Hentunen; Sakamuri V. Reddy; Brendan F. Boyce; Rowena Devlin; Hye-Rim Park; Hoyeon Chung; Katri S. Selander; Mark Dallas; Noriyoshi Kurihara; Deborah L. Galson; et al.

  Immortalization of osteoclast precursors by targeting bcl-X(L) and Simian Virus 40 large T antigen to the osteoclast lineage in transgenic mice

  Journal of Clinical Investigation. 1998;102(1):88-97.
  42

• 166.

  1998

  Maggie J. Nellissery; Susan S. Padalecki; Zoran Brkanac; Frederick R. Singer; G. David Roodman; K. Krishnan Unni; Robin J. Leach; Marc F. Hansen

  Evidence for a novel osteosarcoma tumor-suppressor gene in the chromosome 18 region genetically linked with Paget disease of bone

  American Journal of Human Genetics. 1998;63(3):817-824.
  69

• 167.

  1998

  G. David Roodman

  Animal models of bone disease

  Cancer Research Therapy and Control. 1998;6(1-4):89-90.
  0

• 168.

  1998

  Sakamuri V. Reddy; G. David Roodman

  Control of osteoclast differentiation

  Critical Reviews in Eukaryotic Gene Expression. 1998;8(1):1-17.
  53

• 169.

  1998

  Sun Jin Choi; Rowena D. Devlin; Cheikh Menaa; Hoyeon Chung; G. David Roodman; Sakamuri V. Reddy

  Cloning and identification of human Sca as a novel inhibitor of osteoclast formation and bone resorption

  Journal of Clinical Investigation. 1998;102(7):1360-1368.
  22

• 170.

  1997

  J.D. Cody; F.R. Singer; G.D. Roodman; B. Otterund; T.B. Lewis; M. Leppert; R.J. Leach

  Genetic linkage of Paget disease of the bone to chromosome 18q

  American Journal of Human Genetics. 1997;61(5):1117-1122.
  120

• 171.

  1997

  G. David Roodman

  Mechanisms of bone lesions in multiple myeloma and lymphoma

  Cancer. 1997;80(8 SUPPL.):1557-1563.
  107

• 172.

  1997

  Harry L. Uy; Gregory R. Mundy; Brendan F. Boyce; Beryl M. Story; Colin R. Dunstan; Juan Juan Yin; G. David Roodman; Theresa A. Guise

  Tumor necrosis factor enhances parathyroid hormone-related protein- induced hypercalcemia and bone resorption without inhibiting: Bone formation in vivo

  Cancer Research. 1997;57(15):3194-3199.
  42

• 173.

  1997

  T.W. Tsai; L.A. Hammond; M. Rinaldi; K. Martin; F. Tio; J. Maples; C.O. Freytes; G.D. Roodman

  Cokeromyces recurvatus infection in a bone marrow transplant recipient

  Bone Marrow Transplantation. 1997;19(3):301-302.
  9

• 174.

  1996

  A.M. Parfitt; G.R. Mundy; G.D. Roodman; D.E. Hughes; B.F. Boyce

  A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates

  Journal of Bone and Mineral Research. 1996;11(2):150-159.
  212

• 175.

  1996

  M.P. Whyte; R. Leelawattana; S.V. Reddy; G.D. Roodman

  Absence of paramyxo virus transcripts in juvenile Paget bone disease.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1996;11(7):1041.
  6

• 176.

  1996

  G. David Roodman

  Paget's disease and osteoclast biology

  Bone. 1996;19(3):209-212.
  32

• 177.

  1996

  Melissa Alsina; Theresa A. Guise; G. David Roodman

  Cytokine Regulation of Bone Cell Differentiation

  Vitamins and Hormones. 1996;52(C):63-98.
  28

• 178.

  1996

  B.R. DuPont; R. Linn; C.B. Knight; G.D. Roodman; A.Y. Sakaguchi; P.A. Lalley; R.E.K. Fournier; R.J. Leach

  Assignment of matrix metalloproteinase 9 (Mmp9) to mouse Chromosome 2 bands H1-H2

  Cytogenetics and Cell Genetics. 1996;74(1-2):118-119.
  2

• 179.

  1996

  G. David Roodman

  Advances in bone biology: The osteoclast

  Endocrine Reviews. 1996;17(4):308-332.
  359

• 180.

  1996

  Sakamuri V. Reddy; Orlando Alcantara; G. David Roodman; David H. Boldt

  Inhibition of tartrate-resistant acid phosphatase gene expression by hemin and protoporphyrin IX. Identification of a hemin-responsive inhibitor of transcription

  Blood. 1996;88(6):2288-2297.
  21

• 181.

  1996

  Sakamuri V. Reddy; Frederick R. Singer; Lawrence Mallette; G. David Roodman

  Detection of measles virus nucleocapsid transcripts in circulating blood cells from patients with paget disease

  Journal of Bone and Mineral Research. 1996;11(11):1602-1607.
  60

• 182.

  1996

  Rowena D. Devlin; Henry G. Bone III; G. David Roodman

  Interleukin-6: A potential mediator of the massive osteolysis in patients with Gorham-Stout disease

  Journal of Clinical Endocrinology and Metabolism. 1996;81(5):1893-1897.
  91

• 183.

  1996

  Melissa Alsina; Brendan Boyce; Rowena D. Devlin; Judith L. Anderson; Fiona Craig; Gregory R. Mundy; G. David Roodman

  Development of an in vivo model of human multiple myeloma bone disease

  Blood. 1996;87(4):1495-1501.
  66

• 184.

  1996

  C.O. Frevets; S. Vukelia; D.J. Castro; D. Boldt; G.D. Roodman; S. Hilesbeck; D. Adkins; C. Bachier; F. Craig; N. Clare; et al.

  Rutologous hematopoietic stem cell transplantation for poof prognosis low grade lymphoka

  Experimental Hematology. 1996;24(9):1140.
  0

• 185.

  1995

  S. Takahashi; S. Goldring; M. Katz; S. Hilsenbeck; R. Williams; G.D. Roodman

  Downregulation of calcitonin receptor mRNA expression by calcitonin during human osteoclast-like cell differentiation

  Journal of Clinical Investigation. 1995;95(1):167-171.
  87

• 186.

  1995

  B.F. Boyce; K. Wright; S.V. Reddy; B.A. Koop; B. Story; R. Devlin; R.J. Leach; G.D. Roodman; J.L. Windle

  Targeting simian virus 40 T antigen to the osteoclast in transgenic mice causes osteoclast tumors and transformation and apoptosis of osteoclasts

  Endocrinology. 1995;136(12):5751-5759.
  37

• 187.

  1995

  G.D. Roodman

  Application of bone marrow cultures to the study of osteoclast formation and osteoclast precursors in man

  Calcified Tissue International. 1995;56(1 SUPPL.):S22-S23.
  10

• 188.

  1995

  S.V. Reddy; J.E. Hundley; J.J. Windle; O. Alcantara; R. Linn; R.J. Leach; D.H. Boldt; G.D. Roodman

  Characterization of the mouse tartrate-resistant acid phosphatase (TRAP) gene promoter

  Journal of Bone and Mineral Research. 1995;10(4):601-606.
  51

• 189.

  1995

  S. Takahashi; S.V. Reddy; M. Dallas; R. Devlin; J.Y. Chou; G.D. Roodman

  Development and characterization of a human marrow stromal cell line that enhances osteoclast-like cell formation

  Endocrinology. 1995;136(4):1441-1449.
  33

• 190.

  1995

  H.L. Uy; M. Dallas; J.W. Calland; B.F. Boyce; G.R. Mundy; G.D. Roodman

  Use of an in vivo model to determine the effects of interleukin-1 on cells at different stages in the osteoclast lineage

  Journal of Bone and Mineral Research. 1995;10(2):295-301.
  40

• 191.

  1995

  Sakamuri V. Reddy; Frederick R. Singer; G. David Roodman

  Bone marrow mononuclear cells from patients with Paget's disease contain measles virus nucleocapsid messenger ribonucleic acid that has mutations in a specific region of the sequence

  Journal of Clinical Endocrinology and Metabolism. 1995;80(7):2108-2111.
  81

• 192.

  1995

  J. De La Mata; H.L. Uy; T.A. Guise; B. Story; B.F. Boyce; G.R. Mundy; G.D. Roodman

  Interleukin-6 enhances hypercalcemia and bone resorption mediated by parathyroid hormone-related protein in vivo

  Journal of Clinical Investigation. 1995;95(6):2846-2852.
  168

• 193.

  1995

  Harry L. Uy; Theresa A. Guise; Jose De La Mata; Suzanne D. Taylor; Beryl M. Story; Mark R. Dallas; Brendan F. Boyce; Gregory R. Mundy; G. David Roodman

  Effects of parathyroid hormone (PTH)-related protein and PTH on osteoclasts and osteoclast precursors in vivo

  Endocrinology. 1995;136(8):3207-3212.
  23

• 194.

  1995

  S.V. Reddy; N. Kuzhandaivelu; L.G. Acosta; G.D. Roodman

  Characterization of the 5'-flanking region of the human tartrate-resistant acid phosphatase (TRAP) gene

  Bone. 1995;16(5):587-593.
  14

• 195.

  1995

  Marcjanna Bartkiewicz; Natividad Hernando; Sakamuri V. Reddy; G.David Roodman; Roland Baron

  Characterization of the osteoclast vacuolar H⁺-ATPase B-subunit

  Gene. 1995;160(2):157-164.
  17

• 196.

  1995

  G.D. Roodman

  Osteoclast function in Paget's disease and multiple myeloma

  Bone. 1995;17(2 SUPPL.):57S-61S.
  30

• 197.

  1995

  M. Alsina; B.F. Boyce; G.R. Mundy; G.D. Roodman

  An in vivo model of human multiple myeloma bone disease

  Stem Cells. 1995;13(SUPPL. 2):48-50.
  7

• 198.

  1995

  D.E. Hughes; K.R. Wright; H.L. Uy; A. Sasaki; T. Yoneda; G.D. Roodman; G.R. Mundy; B.F. Boyce

  Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo

  Journal of Bone and Mineral Research. 1995;10(10):1478-1487.
  663

• 199.

  1994

  Shunji Takahashi; Sakamuri V. Reddy; John M. Chirgwin; Rowena Devlin; Carrie Haipek; Judy Anderson; G. David Roodman

  Cloning and identification of annexin II as an autocrine/paracrine factor that increases osteoclast formation and bone resorption

  Journal of Biological Chemistry. 1994;269(46):28696-28701.
  59

• 200.

  1994

  Douglas R. Adkins; Donna Salzman; David Boldt; John Kuhn; Rebecca Irvin; G. David Roodman; Roger Lyons; Lon Smith; Cesar O. Freytes; et al.

  Phase I trial of dacarbazine with cyclophosphamide, carmustine, etoposide, and autologous stem-cell transplantation in patients with lymphoma and multiple myeloma

  Journal of Clinical Oncology. 1994;12(9):1890-1901.
  6

• 201.

  1994

  G.D. Roodman

  Biology of the osteoclast in Paget's disease

  Seminars in Arthritis and Rheumatism. 1994;23(4):235-236.
  3

• 202.

  1994

  B.G. Mills; A. Frausto; F.R. Singer; Y. Ohsaki; A. Demulder; G.D. Roodman

  Multinucleated cells formed in vitro from Paget's bone marrow express viral antigens

  Bone. 1994;15(4):443-448.
  47

• 203.

  1994

  Sakamuri V. Reddy; Shunji Takahashi; Mark Dallas; Ronald E. Williams; Leonard Neckers; G. David Roodman

  Interleukin-6 antisense deoxyoligonucleotides inhibit bone resorption by giant cells from human giant cell tumors of bone

  Journal of Bone and Mineral Research. 1994;9(5):753-757.
  46

• 204.

  1994

  O. Alcantara; S.V. Reddy; G.D. Roodman; D.H. Boldt

  Transcriptional regulation of the tartrate-resistant acid phosphatase (TRAP) gene by iron

  Biochemical Journal. 1994;298(2):421-425.
  24

• 205.

  1993

  W.E. Gallwitz; G.R. Mundy; C.H. Lee; M. Qiao; G.D. Roodman; M. Raftery; S.J. Gaskell; L.F. Bonewald

  5-Lipoxygenase metabolites of arachidonic acid stimulate isolated osteoclasts to resorb calcified matrices

  Journal of Biological Chemistry. 1993;268(14):10087-10094.
  56

• 206.

  1993

  G.D. Roodman

  Role of cytokines in the regulation of bone resorption

  Calcified Tissue International. 1993;53(SUPPL. 1):S94-S98.
  106

• 207.

  1993

  D.R. Adkins; R. Irvin; J. Kuhn; D.H. Boldt; G.D. Roodman; D. Salzman; C. Freytes; D.D. Von Hoff; C.F. LeMaistre

  A phase I clinical and pharmacological profile of dacarbazine with autologous bone marrow transplantation in patients with solid tumors

  Investigational New Drugs. 1993;11(2-3):169-179.
  5

• 208.

  1993

  S.V. Reddy; S. Takahashi; C. Haipek; J.M. Chirgwin; G.D. Roodman

  Tartrate-resistant acid phosphatase gene expression as a facile reporter gene for screening transfection efficiency in mammalian cell cultures

  BioTechniques. 1993;15(3):444-446.
  3

• 209.

  1993

  S.V. Reddy; T. Scarcez; J.J. Windle; R.J. Leach; J.E. Hundley; J.M. Chirgwin; J.Y. Chou; G.D. Roodman

  Cloning and characterization of the 5'-flanking region of the mouse tartrate-resistant acid phosphatase gene

  Journal of Bone and Mineral Research. 1993;8(10):1263-1270.
  28

• 210.

  1993

  T.C. Hardin; J.M. Koeller; J.G. Kuhn; G.D. Roodman; D.D. Von Hoff

  Nutritional parameters observed during 28-day infusion of recombinant human tumor necrosis factor-α

  Journal of Parenteral and Enteral Nutrition. 1993;17(6):541-545.
  3

• 211.

  1993

  R. Grimes; S.V. Reddy; R.J. Leach; T. Scarcez; G.D. Roodman; A.Y. Sakaguchi; P.A. Lalley; J.J. Windle

  Assignment of the mouse tartrate-resistant acid phosphatase gene (Acp5) to Chromosome 9

  Genomics. 1993;15(2):421-422.
  11

• 212.

  1993

  J.R. Eckardt; G.D. Roodman; D.H. Boldt; G.M. Clark; R. Alvarez; C. Page; H. Gaskill; C.F. LeMaistre

  Comparison of engraftment and acute GVHD in patients undergoing cryopreserved or fresh allogeneic BMT

  Bone Marrow Transplantation. 1993;11(2):125-131.
  19

• 213.

  1993

  A. Demulder; S. Takahashi; F.R. Singer; D.J. Hosking; G.D. Roodman

  Abnormalities in osteoclast precursors and marrow accessory cells in Paget's disease

  Endocrinology. 1993;133(5):1978-1982.
  45

• 214.

  1993

  M.V. Marshall; M.H. Marshall; D.R. Degen; G.D. Roodman; J.G. Kuhn; M.E. Ross; D.D. Von Hoff

  In vitro cytotoxicity of hepsulfam against human tumor cell lines and primary human tumor colony forming units

  Stem Cells. 1993;11(1):62-69.
  3

• 215.

  1993

  C.L. Hardy; J.J. Minguell; G.D. Roodman; J.S. Greenberger; T.D. Allen

  Cellular interactions in hemopoietic progenitor cell homing: A review

  Scanning Microscopy. 1993;7(1):333-341.
  11

• 216.

  1992

  Y. Ohsaki; S. Takahashi; T. Scarcez; A. Demulder; T. Nishihara; R. Williams; G.D. Roodman

  Evidence for an autocrine/paracrine role for interleukin-6 in bone resorption by giant cells from giant cell tumors of bone

  Endocrinology. 1992;131(5):2229-2234.
  105

• 217.

  1992

  G.R. Mundy; G.D. Roodman; L.F. Bonewald; T. Yoneda; M. Sabatini

  Effects of TNF and lymphotoxin on bone cells.

  Immunology series. 1992;56:483-498.
  3

• 218.

  1992

  G.D. Roodman; N. Kurihara; Y. Ohsaki; A. Kukita; D. Hosking; A. Demulder; J.F. Smith; F.R. Singer

  Interleukin 6: A potential autocrine/paracrine factor in Paget's disease of bone

  Journal of Clinical Investigation. 1992;89(1):46-52.
  207

• 219.

  1992

  A. Demulder; S.V. Suggs; K.M. Zsebo; T. Scarcez; G.D. Roodman

  Effects of stem cell factor on osteoclast-like cell formation in long-term human marrow cultures

  Journal of Bone and Mineral Research. 1992;7(11):1337-1344.
  24

• 220.

  1992

  G.D. Roodman

  Perspectives: Interleukin-6: An osteotropic factor?

  Journal of Bone and Mineral Research. 1992;7(5):475-478.
  197

• 221.

  1991

  G.D. Roodman

  Osteoclast differentiation

  Critical Reviews in Oral Biology and Medicine. 1991;2(3):389-409.
  15

• 222.

  1991

  M.C. Sunderland; G.D. Roodman

  Interleukin-3: Its biology and potential uses in pediatric hematology/oncology

  American Journal of Pediatric Hematology/Oncology. 1991;13(4):414-425.
  3

• 223.

  1991

  G.D. Roodman; T.J. Kuehl; J.L. Vandeberg; D.Y. Muirhead

  In utero bone marrow transplantation of fetal baboons with mismatched adult baboon marrow

  Blood Cells. 1991;17(2):367-375.
  18

• 224.

  1991

  N. Kurihara; C. Civin; G.D. Roodman

  Osteotropic factor responsiveness of highly purified populations of early and late precursors for human multinucleated cells expressing the osteoclast phenotype

  Journal of Bone and Mineral Research. 1991;6(3):257-261.
  58

• 225.

  1991

  G.R. Mundy; G.D. Roodman; L.F. Bonewald; R.O.C. Oreffo; B.F. Boyce

  Assays for bone resorption and bone formation

  Methods in Enzymology. 1991;198:502-510.
  8

• 226.

  1990

  N. Kurihara; G.D. Roodman

  Interferons-α and -γ inhibit interleukin-1β-stimulated osteoclast-like cell formation in long-term human marrow cultures

  Journal of Interferon Research. 1990;10(5):541-547.
  32

• 227.

  1990

  G.R. Mundy; G.D. Roodman; T. Yoneda; L. Bonewald; R. Oreffo

  Growth regulatory factors and bone cell function

  Calcium regulation and bone metabolism. Basic and clinical aspects: proceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886. 1990:257-269.
  0

• 228.

  1990

  G.D. Roodman; R.A. Johnson; U. Clibon

  Tumor necrosis factor α and the anemia of chronic disease: Effects of chronic exposure to TNF on erythropoiesis in vivo

  Advances in Experimental Medicine and Biology. 1990;271:185-196.
  14

• 229.

  1990

  U. Clibon; L. Bonewald; J. Caro; G.D. Roodman

  Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo

  Experimental Hematology. 1990;18(5):438-441.
  16

• 230.

  1990

  T. Yoneda; G.R. Mundy; G.D. Roodman

  Induction of differentiation of the human promyelocytic HL-60 cells into cells with the osteoclastic phenotype

  Calcium regulation and bone metabolism. Basic and clinical aspects: proceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886. 1990:425-429.
  0

• 231.

  1990

  A. Kukita; C. Chenu; L. McManus; G. Mundy; G.D. Roodman

  Abnormal osteoclast-like cells form in Pagetic marrow cultures

  Calcium regulation and bone metabolism. Basic and clinical aspects: proceedings of the 10th International Conference on calcium regulating hormones and bone metabolism. ICS886. 1990:430-433.
  0

• 232.

  1990

  D.Y. Muirhead; T.J. Kuehl; J.L. Vandeberg; E.M. Menchaca; M.P. Downs; G.D. Roodman

  Mixed lymphocyte culture reactivity of fetal baboons: Application for in utero bone marrow transplantation

  Bone Marrow Transplantation. 1990;6(4):263-267.
  1

• 233.

  1990

  C. Chenu; N. Kurihara; G.R. Mundy; G.D. Roodman

  Prostaglandin E₂ inhibits formation of osteoclastlike cells in long-term human marrow cultures but is not a mediator of the inhibitory effects of transforming growth factor β

  Journal of Bone and Mineral Research. 1990;5(7):677-681.
  30

• 234.

  1990

  A. Kukita; L. Bonewald; D. Rosen; S. Seyedin; G.R. Mundy; G.D. Roodman

  Osteoinductive factor inhibits formation of human osteoclast-like cells

  Proceedings of the National Academy of Sciences of the United States of America. 1990;87(8):3023-3026.
  15

• 235.

  1990

  N. Kurihara; C. Chenu; M. Miller; C. Civin; G.D. Roodman

  Identification of committed mononuclear precursors for osteoclast-like cells formed in long term human marrow cultures

  Endocrinology. 1990;126(5):2733-2741.
  121

• 236.

  1990

  N. Kurihara; D. Bertolini; T. Suda; Y. Akiyama; G.D. Roodman

  IL-6 stimulates osteoclast-like multinucleated cell formation in long term human marrow cultures by inducing IL-1 release

  Journal of Immunology. 1990;144(11):4226-4230.
  229

• 237.

  1990

  A. Kukita; C. Chenu; L.M. McManus; G.R. Mundy; G.D. Roodman

  Atypical multinucleated cells form in long-term marrow cultures from patients with Paget's disease

  Journal of Clinical Investigation. 1990;85(4):1280-1286.
  39

• 238.

  1990

  N. Kurihara; S. Gluck; G.D. Roodman

  Sequential expression of phenotype markers for osteoclasts during differentiation of precursors for multinucleated cells formed in long term human marrow cultures

  Endocrinology. 1990;127(6):3215-3221.
  27

• 239.

  1989

  T. Kukita; G.D. Roodman

  Development of a monoclonal antibody to osteoclasts formed in vitro which recognizes mononuclear osteoclast precursors in the marrow

  Endocrinology. 1989;125(2):630-637.
  8

• 240.

  1989

  T. Kukita; L.M. McManus; M. Miller; C. Civin; G.D. Roodman

  Osteoclast-like cells formed in long-term human bone marrow cultures express a similar surface phenotype as authentic osteoclasts

  Laboratory Investigation. 1989;60(4):532-538.
  19

• 241.

  1989

  R.A. Johnson; T.A. Waddelow; J. Caro; A. Oliff; G.D. Roodman

  Chronic exposure to tumor necrosis factor in vivo preferentially inhibits erythropoiesis in nude mice

  Blood. 1989;74(1):130-138.
  84

• 242.

  1989

  R.A. Johnson; G.D. Roodman

  Hematologic manifestations of malignancy

  Disease-a-Month. 1989;35(11):726-759.
  10

• 243.

  1989

  R.A. Johnson; B.F. Boyce; G.R. Mundy; G.D. Roodman

  Tumors producing human tumor necrosis factor induce hypercalcemia and osteoclastic bone resorption in nude mice

  Endocrinology. 1989;124(3):1424-1427.
  73

• 244.

  1989

  D.M. Williams; L.F. Bonewald; G.D. Roodman; G.I. Byrne; D.M. Magee; J. Schachter

  Tumor necrosis factor alpha is a cytotoxin induced by murine Chlamydia trachomatis infection

  Infection and Immunity. 1989;57(5):1351-1355.
  21

• 245.

  1989

  J. Pfeilschifter; C. Chenu; A. Bird; G.R. Mundy; G.D. Roodman

  Interleukin-1 and tumor necrosis factor stimulate the formation of human osteoclastlike cells in vitro

  Journal of Bone and Mineral Research. 1989;4(1):113-118.
  215

• 246.

  1989

  N. Takahashi; T. Kukita; B.R. MacDonald; A. Bird; G.R. Mundy; L.M. McManus; M. Miller; A. Boyde; S.J. Jones; G.D. Roodman

  Osteoclast-like cells form in long-term human bone marrow but not in peripheral blood cultures

  Journal of Clinical Investigation. 1989;83(2):543-550.
  25

• 247.

  1989

  Robert A. Johnson; G.David Roodman

  Hematologic manifestations of malignancy

  Disease-a-Month. 1989;35(11):726-768.
  11

• 248.

  1989

  X.-F. Li; J. Anderson; D. Hutzler; G.D. Roodman

  Hemin-induced erythroid differentiation changes the sensitivity of K562 cells to tumor necrosis factor-α

  Experimental Hematology. 1989;17(11):1059-1062.
  4

• 249.

  1988

  G.D. Roodman; J.L. Vandeberg; T.J. Kuehl

  In utero bone marrow transplantation of fetal baboons with mismatched adult marrow: Initial observations

  Bone Marrow Transplantation. 1988;3(2):141-147.
  3

• 250.

  1988

  N. Takahashi; H. Yamana; S. Yoshiki; G.D. Roodman; G.R. Mundy; S.J. Jones; A. Boyde; T. Suda

  Osteoclast-like cell formation and its regulation by osteotropic hormones in mouse bone marrow cultures

  Endocrinology. 1988;122(4):1373-1382.
  407

• 251.

  1988

  G.D. Roodman

  Model systems of osteoclast differentiation

  Journal of Bone and Mineral Metabolism. 1988;6(3):1-11.
  1

• 252.

  1988

  C. Chenu; J. Pfeilschifter; G.R. Mundy; G.D. Roodman

  Transforming growth factor β inhibits formation of osteoclast-like cells in long-term human marrow cultures

  Proceedings of the National Academy of Sciences of the United States of America. 1988;85(15):5683-5687.
  123

• 253.

  1987

  B.R. MacDonald; N. Takahashi; L.M. McManus; J. Holahan; G.R. Mundy; G.D. Roodman

  Formation of multinucleated cells that respond to osteotropic hormones in long term human bone marrow cultures

  Endocrinology. 1987;120(6):2326-2336.
  65

• 254.

  1987

  G.D. Roodman

  Mechanisms of erythroid suppression in the anemia of chronic disease

  Blood Cells. 1987;13(1-2):171-184.
  13

• 255.

  1987

  N. Takahashi; G.R. Mundy; T.J. Kuehl; G.D. Roodman

  Osteoclast-like cell formation in fetal and newborn long-term baboon marrow cultures is more sensitive to 1,25-dihydroxyvitamin D3 than adult long-term marrow cultures.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1987;2(4):311-317.
  9

• 256.

  1987

  G.D. Roodman; C.F. LeMaistre; G.M. Clark; C.P. Page; T.F. Newcomb; W.A. Knight 3rd.

  CFU-GEMM correlate with neutrophil and platelet recovery in patients receiving autologous marrow transplantation after high-dose melphalan chemotherapy.

  Bone Marrow Transplantation. 1987;2(2):165-173.
  7

• 257.

  1987

  F.H. Gardner; J.B. Alperin; J.A. Belli; P.C. Farley; E.P. Frenkel; J.R. Redman; G.D. Roodman; D.A. Sears; A.A. Trowbridge Jr.

  Hematology-oncology. Hematology-Oncology Workgroup, Legislative Task Force on Cancer in Texas.

  Texas Medicine. 1987;83(9 Pt 2):59-71.
  0

• 258.

  1987

  J.C. Lee; T.J. Kuehl; G.D. Roodman

  Developmental changes in membrane proteins from baboon erythrocytes.

  Comparative biochemistry and physiology. B, Comparative biochemistry. 1987;88(1):223-226.
  0

• 259.

  1987

  G.D. Roodman; A. Bird; D. Hutzler; W. Montgomery

  Tumor necrosis factor-alpha and hematopoietic progenitors: Effects of tumor necrosis factor on the growth of erythroid progenitors CFU-E and BFU-E and the hematopoietic cell lines K562, HL60, and HEL cells

  Experimental Hematology. 1987;15(9):928-935.
  65

• 260.

  1987

  John C. Lee; Thomas J. Kuehl; G.David Roodman

  Developmental changes in membrane proteins from baboon erythrocytes

  Comparative Biochemistry and Physiology -- Part B: Biochemistry and. 1987;88(1):233-236.
  0

• 261.

  1986

  B.R. MacDonald; G.R. Mundy; S. Clark; E.A. Wang; T.J. Kuehl; E.R. Stanley; G.D. Roodman

  Effects of human recombinant CSF-GM and highly purified CSF-1 on the formation of multinucleated cells with osteoclast characteristics in long-term bone marrow cultures.

  Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research. 1986;1(2):227-233.
  62

• 262.

  1986

  N. Takahashi; B.R. MacDonald; J. Hon; M.E. Winkler; R. Derynck; G.R. Mundy; G.D. Roodman

  Recombinant human transforming growth factor-alpha stimulates the formation of osteoclast-like cells in long-term human marrow cultures

  Journal of Clinical Investigation. 1986;78(4):894-898.
  41

• 263.

  1986

  N. Takahashi; G.R. Mundy; G.D. Roodman

  Recombinant human interferon-γ inhibits formation of human osteoclast-like cells

  Journal of Immunology. 1986;137(11):3544-3549.
  77

• 264.

  1985

  G.D. Roodman; K.J. Ibbotson; B.R. MacDonald; T.J. Kuehl; G.R. Mundy

  1,25-dihydroxyvitamin D₃ causes formation of multinucleated cells with several osteoclast characteristics in cultures of primate marrow

  Proceedings of the National Academy of Sciences of the United States of America. 1985;82(23):8213-8217.
  87

• 265.

  1985

  G.D. Roodman; J.L. VandeBerg; T.J. Kuehl

  Expression of latent hematopoietic progenitor cells in cultures of newborn and adult baboon liver

  Blood. 1985;65(6):1518-1525.
  2

• 266.

  1985

  G.D. Roodman

  Changes in the growth requirements of baboon liver hematopoietic progenitors during ontogeny.

  Progress in clinical and biological research. 1985;193:43-54.
  0

• 267.

  1984

  K.J. Ibbotson; G.D. Roodman; L.M. McManus; G.R. Mundy

  Identification and characterization of osteoclast-like cells and their progenitors in cultures of feline marrow mononuclear cells

  Journal of Cell Biology. 1984;99(2):471-480.
  66

• 268.

  1983

  G.D. Roodman; J. Lee; A.S. Gidari

  Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow

  British Journal of Haematology. 1983;53(4):621-628.
  7

• 269.

  1983

  G.D. Roodman; V.W. Horadam; T.L. Wright

  Inhibition of erythroid colony formation by autologous bone marrow adherent cells from patients with the anemia of chronic disease

  Blood. 1983;62(2):406-412.
  10

• 270.

  1982

  G.D. Roodman; C.N. Clare; G. Mills

  Congenital dyserythropoietic anaemia type II (CDA-II): Chromosome banding studied and adherent cell effects on erythroid colony (CFU-E) and burst (BFU-E) formation

  British Journal of Haematology. 1982;50(3):499-507.
  3

• 271.

  1981

  G.D. Roodman; J.M. Kaplan; M.E. Kaplan; E.D. Zanjani

  Effects of shortened erythropoietin exposure on sheep marrow cultures

  British Journal of Haematology. 1981;47(2):195-201.
  0

• 272.

  1981

  G.D. Roodman; J.L. Spivak; E.D. Zanjani

  Stimulation of erythroid colony formation in vitro by erythropoietin immobilized on agarose-bound lectins

  Journal of Laboratory and Clinical Medicine. 1981;98(5):684-690.
  0

• 273.

  1980

  G.D. Roodman; J.L. Ascensao; M. Banisadre; P.M. Bloom; E.D. Zanjani

  Autoimmune pancytopenia. Lymphocyte inhibition of autologous but not allogenic bone marrow growth in vitro

  American Journal of Medicine. 1980;69(2):325-328.
  1

• 274.

  1980

  G.D. Roodman; E.P. Reese Jr.; J.M. Cardamone

  Aplastic anemia associated with rubber cement used by a marathon runner

  Archives of Internal Medicine. 1980;140(5):703.
  0

• 275.

  1979

  G.D. Roodman; E.D. Zanjani

  Endogenous erythroid colony-forming cells in fetal and newborn sheep

  Journal of Laboratory and Clinical Medicine. 1979;94(5):699-707.
  3

• 276.

  1976

  G.D. Roodman; J.J. Hutton; F.J. Bollum

  DNA polymerase, thymidine kinase and DNA synthesis in erythropoietic mouse spleen cells separated on bovine serum albumin gradients

  Biochimica et Biophysica Acta. 1976;425(4):478-491.
  3

• 277.

  1975

  G.D. Roodman; J.J. Hutton; F.J. Bollum

  DNA polymerase activities during erythropoiesis. Effects of erythropoietin, vinblastine, colcemid, and daunomycin

  Experimental Cell Research. 1975;91(2):269-278.
  1